Investigation of the Role of Bcyrn1-Induced De Novo Purine Synthesis in Glioblastoma Progression and the Potential of Serum Exosomal Bcyrn1 as Rognostic Biomarker

結果顯示BC200可能調節嘌呤代謝途徑並參與膠質母細胞瘤的形成。基於這些初步研究數據，我們提出透由BC200靶向嘌呤體形成，藉此實現可應用於膠質母細胞瘤之新穎治療方案。